Annual report pursuant to Section 13 and 15(d)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.8.0.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2017
Accounting Policies [Abstract]  
Schedule of goodwill
Balance as of January 1, 2017   $ -  
Goodwill recorded in connection with the acquisition of the Biotest Assets     3,529,509  
Balance as of December 31, 2017   $ 3,529,509  
Schedule of assumptions used for equity compensation expense
    Year Ended   Year Ended
    December 31, 2017   December 31, 2016
Expected term     5.8-6.3 years       5.8-6.3 years  
Volatility     56-64       51-52  
Dividend yield     0.0       0.0  
Risk-free interest rate     1.77-2.29%       1.54-1.79%  
Schedule of dilutive securities
    For the year ended December 31,
    2017   2016
Stock options     3,276,043       1,535,187  
Warrants     528,160       300,446  
      3,804,203       1,835,633